Change In Fair Value Due To Credit Risk

No definition available.

Name:	sclx_ChangeInFairValueDueToCreditRisk
Namespace Prefix:	sclx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Change In Fair Value Of Convertible Debentures Include Interest Expense

+ References

No definition available.

+ Details

Name:	sclx_ChangeInFairValueOfConvertibleDebenturesIncludeInterestExpense
Namespace Prefix:	sclx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Derivative Warrant Liabilities

+ References

No definition available.

+ Details

Name:	sclx_DerivativeWarrantLiabilities
Namespace Prefix:	sclx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Fair value of contingent consideration.

+ References

No definition available.

+ Details

Name:	sclx_FairValueOfContingentConsideration
Namespace Prefix:	sclx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Secured Note Discount Rate

+ References

No definition available.

+ Details

Name:	sclx_SecuredNoteDiscountRate
Namespace Prefix:	sclx_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of contingent consideration recognized as part of consideration transferred in asset acquisition.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 25
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480060/805-50-25-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 30
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480027/805-50-30-1

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 30
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480027/805-50-30-2

+ Details

Name:	us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Exercise price per share or per unit of warrants or rights outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-3

+ Details

Name:	us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of warrants or rights outstanding.

+ References

No definition available.

+ Details

Name:	us-gaap_ClassOfWarrantOrRightOutstanding
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69B
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69C
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482907/825-10-50-10

+ Details

Name:	us-gaap_DebtInstrumentFairValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of principal of debt issued.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-03(i)(1))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3

+ Details

Name:	us-gaap_DebtInstrumentIssuedPrincipal
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4A
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A

+ Details

Name:	us-gaap_DerivativeGainLossOnDerivativeNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Rate applied to the undiscounted amount of estimated damages for product liability to arrive at the present value recorded as of the balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 5.Y.Q1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480102/450-20-S99-1

+ Details

Name:	us-gaap_ProductLiabilityContingencyAccrualDiscountRate
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_SubsidiarySaleOfStockLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_AwardTypeAxis=sclx_WarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorSubordinatedNotesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=sclx_FirmWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=sclx_RdoCommonWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=sclx_RepresentativeWarrantsOutstandingMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=sclx_WarrantTransferAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Fair Value Measurements (Additional Information) (Details) - USD ($) $ / shares in Units, $ in Thousands			1 Months Ended	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Apr. 30, 2023	Sep. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Feb. 29, 2024
Subsidiary, Sale of Stock [Line Items]
Note discount rate						3027.00%
Principle amount of issued debt		$ 25,000
Warrants outstanding	6,854,309			6,854,309		6,854,309		6,854,309
Loss on derivative liability				$ 15,284	$ 82	$ 15,741	$ 5,335
Common stock upon conversation of cash						$ 3,000
Discount rate of FDA	10.80%			10.80%		10.80%
Development Milestone Payment						$ 200		$ 200
Derivative warrant liabilities						30,000
Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Loss on derivative liability				$ 15,300	$ 100	15,700	$ 5,300
Price per share									$ 2.125
Oramed Note
Subsidiary, Sale of Stock [Line Items]
Estimated fair value	$ 75,400			75,400		75,400
Principle amount of issued debt	10,000		$ 101,900
Change in fair value due to credit risk				1,900		1,900
Change in fair value of debt and liability instruments				4,300		8,100
FSF Deposit
Subsidiary, Sale of Stock [Line Items]
Estimated fair value	$ 11,700			11,700		$ 11,700
Note discount rate						3566.00%
Change in fair value of debt and liability instruments				$ 1,700		$ 1,700
Private Placement [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants outstanding	3,613,383			3,613,383		3,613,383
Firm Warrants[Member]
Subsidiary, Sale of Stock [Line Items]
Warrants outstanding	5,832,653			5,832,653		5,832,653
RDO Common Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants outstanding	15,000,000			15,000,000		15,000,000
Representative Warrants Outstanding[Member]
Subsidiary, Sale of Stock [Line Items]
Warrants outstanding	470,588			470,588		470,588
Warrant Transfer Agreement [Member] \| Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants outstanding	3,613,383			3,613,383		3,613,383		3,613,383
Price per share	$ 0.01			$ 0.01		$ 0.01